NOUREX
Live / Applied — Fourth extension granted (statement of use) (as of 15 Dec 2025)
What this means for you
Not registered yet, but its 14 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97794497
- Mark type
- Stylized text
- Filed
- 14 Feb 2023
- Published for opposition
- 23 Jan 2024
- Attorney of record
- Aaron Sternhagen
Goods and services
- Class 005 — Pharmaceuticals: Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals
Owner
- Elanco US Inc., Indianapolis, IN, US
- Elanco US Inc., Greenfield, IN, US
Prosecution history
- 16 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2025 — SOU EXTENSION 4 GRANTED
- 15 Dec 2025 — SOU EXTENSION 4 FILED
- 15 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2025 — SOU EXTENSION 3 GRANTED
- 29 Jul 2025 — SOU EXTENSION 3 FILED
- 29 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2025 — SOU EXTENSION 2 GRANTED
- 05 Feb 2025 — SOU EXTENSION 2 FILED
- 05 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2024 — SOU EXTENSION 1 GRANTED
- 12 Sept 2024 — SOU EXTENSION 1 FILED